| | 
Part, Chapter, Paragraph
1 I, 2. 5 | employment from 66 per cent in 1995 to 71 per cent in 2005 in
2 I, 2. 10. 3 | adaptation (Freeman, et al, 1995) 7.The process of structural
3 I, 2. 10. 3(7)| Soete L, Efendioglu U (1995): Diffusion and the employment
4 I, 2. 11 | Soete L, Efendioglu U (1995): Diffusion and the employment
5 I, 3. 1 | from 2.51 to 1.25 (1963- 1995). Fertility decline was
6 I, 3. 1 | than for women (Toulemon, 1995). Research shows that having
7 I, 3. 4 | 231-251.~ ~Toulemon, L (1995): The Place of Children
8 II, 4. 1 | ECHP) study run between 1995 and 2001. Relevant questions
9 II, 4. 1 | disabilities.~ ~LE estimates from 1995 to 2005 for the 27 current
10 II, 4. 1 | DFLE65 /LE65 computed from 1995 to 2001 with the ECHP survey.~ ~
11 II, 4. 1 | consider a gain of 5% between 1995 and 2001 to signify compression
12 II, 4. 1 | European Union (EU27), from 1995 to 2005, per gender~ ~Over
13 II, 4. 1 | Over the 10 year period 1995-2005, life expectancy at
14 II, 4. 1 | gaps between the MS since 1995.~ ~Table 4.1.4. Minimum
15 II, 4. 1 | the EU27, USA and Japan in 1995 and in 2005 and by gender.
16 II, 4. 1 | America (USA) and in Japan in 1995 and 2005, per gender~ ~Table
17 II, 4. 1 | over the 10-year period 1995-2005 and the second largest (
18 II, 4. 3 | the European Union since 1995: similarities and differences
19 II, 5. 2. 4 | surveys were conducted in 1995-96, 1999-2000 and 2005-6
20 II, 5. 3. 6 | presents survival data in 1995-1999 and 2000-2002. In this
21 II, 5. 3. 6 | Patients diagnosed in 1995-1999~Berrino et al (2007)
22 II, 5. 3. 6 | cases that were diagnosed in 1995–99 and followed up to December,
23 II, 5. 3. 6 | TNEH. Data for 1990–94 and 1995–99 showed a survival increase
24 II, 5. 3. 9 | European adults diagnosed in 1995–99: results of the EUROCARE-4
25 II, 5. 4. 2 | 2002; Azzopardi et al. 1995; Beck et al. 2001), or by
26 II, 5. 4. 8 | Mazovetsky A, Olchanski V., (1995) A computerized health screening
27 II, 5. 4. 8 | diabetes mellitus, Diabet Med. 1995 Mar;12(3):271-6~Beck, P,
28 II, 5. 4. 8 | Global burden of diabetes, 1995-2025: prevalence, numerical
29 II, 5. 5. 1 | standardized death rate) in 1995 and 2005 in the EU. Source:
30 II, 5. 5. 3 | Misra et al, 2004; Gupta, 1995). Anorexia is a psychological
31 II, 5. 5. 3 | and young women (Gupta, 1995). Young girls and boys follow
32 II, 5. 5. 3 | potential infertility (Gupta, 1995). Therefore, an early diagnosis
33 II, 5. 5. 3 | March 2008).~Gupta M A (1995): Concerns About Aging and
34 II, 5. 5. 3 | exception (Cockerell et al, 1995), the incidence of epilepsy
35 II, 5. 5. 3 | study (Cockerell et al, 1995) age-specific incidence
36 II, 5. 5. 3 | incidence studies (Nashef et al, 1995). The patient at risk for
37 II, 5. 5. 3 | of age (Cockerell et al, 1995). The 5-year remission rate
38 II, 5. 5. 3 | seriously behind (Thompson, 1995). Studies made in Finland
39 II, 5. 5. 3 | I, Goodridge DM, et al (1995): Epilepsy in a population
40 II, 5. 5. 3 | Fish DR, Garner S, et al (1995): Sudden death in epilepsy :
41 II, 5. 5. 3 | 41:998-1004.~Thompson PJ (1995): The impact of epilepsy
42 II, 5. 5. 3 | Sudomoina M, Turetskaya R (1995): Epidemiology of multiple
43 II, 5. 5. 3 | prevalence on 1 January 1995 and incidence over a 25-
44 II, 5. 5. 3 | prevalence and incidence 1993-1995. Neurol Neurochir Pol 33:
45 II, 5. 5. 3 | Fraser M, Compston DAS (1995): multiple sclerosis in
46 II, 5. 5. 3 | al, 2002; de Rijk et al, 1995; Granieri et al, 1991; Schrag
47 II, 5. 5. 3 | department of statistics in, 1995 (Bundesministerium für Gesundheit,
48 II, 5. 5. 3 | Bundesministerium für Gesundheit, 1995). PD patients retired at
49 II, 5. 5. 3 | due to PD (Clarke et al, 1995).~ ~
50 II, 5. 5. 3 | Bundesministerium für Gesundheit., 1995. Daten des Gesundheitswesen.
51 II, 5. 5. 3 | Zobkiw RM, Gullaksen E (1995): Quality of life and care
52 II, 5. 5. 3 | der Meche FG, Hofman A (1995): Prevalence of Parkinson’
53 II, 5. 6. 3 | previous year ( Natvig et al, 1995). They were the most common
54 II, 5. 6. 3 | occur spontaneously (Melton, 1995).~ ~Table 5.6.8. Risk Factors
55 II, 5. 6. 3 | density (Cummings et al, 1995) can identify those at much
56 II, 5. 6. 4 | respiratory disorders (Stansfeld, 1995). Musculoskeletal complaints
57 II, 5. 6. 6 | Cauley J, Black D, Vogt TM (1995): Risk factors for hip fracture
58 II, 5. 6. 6 | 111-115~Melton LJ, III (1995): Epidemiology of fractures.
59 II, 5. 6. 6 | Bruusgaard D, Rutle O (1995): Musculoskeletal symptoms
60 II, 5. 6. 6 | Cirillo PA, Walker AM (1995): Incidence of symptomatic
61 II, 5. 6. 6 | Canner R, North F, Marmot M (1995): Sickness absence for psychiatric
62 II, 5. 7. 3 | 1990-1994) and 12% (cohort 1995-1999) lower risk of death.
63 II, 5. 8. 4 | gender (Siafakas et al, 1995). But a study by Soriano
64 II, 5. 9. 3 | seems to have decreased from 1995 until 2005 (-52%) (Tuberkulóza
65 II, 5. 9. 7 | olds in the British Isles, 1995-2002: Questionnaire survey.
66 II, 5. 10. 2 | and other cereals (SCF, 1995).~ ~
67 II, 5. 10. 7 | Committee for Foods (SCF) (1995): Report on adverse reactions
68 II, 5. 11. 3 | supervision) (Williams et al, 1995). Prevalence estimates for
69 II, 5. 11. 3 | community survey (Neame et al, 1995).~Although there are no
70 II, 5. 11. 3 | 13 to 39% during the 1985–1995 period (L Mattila et al.
71 II, 5. 11. 3 | in Finland, in the years 1995–97 and 2000–02 the patch
72 II, 5. 11. 3 | to cosmetic allergens in 1995–1997 and 2000–2002 in Finland –
73 II, 5. 11. 3 | Finnish university students in 1995, Contact Dermatitis, 2001;
74 II, 5. 11. 3 | registered between 1961 and 1995 (Levi et al, 2001). Incidence
75 II, 5. 11. 3 | 2001).~Between 1978 and 1995, the Slovakian Cancer Registry
76 II, 5. 11. 7 | Berth-Jones J, Kurinczuk JJ et al (1995): prevalence of atopic dermatitis
77 II, 5. 11. 7 | variation. Br J Dermatol 1995;132:772-7.~ ~National Institute
78 II, 5. 11. 7 | cancer in Slovakia, (1978–1995). Neoplasma (2000):47:137–
79 II, 5. 11. 7 | Pembroke AC, Forsdyke H et al (1995): London-born black Carriben
80 II, 5. 11. 7 | dermatitis. J Am Acad Dermatol 1995;32:212-217.~ ~Williams HC (
81 II, 6. 2 | on trends for the years 1995–20041. This information
82 II, 6. 3. 1 | Summary of general trends (1995–2005), EU incidence (2005),
83 II, 6. 3. 3 | has been declining since 1995, when the AIDS incidence
84 II, 6. 3. 3 | increasing trends over the period 1995–2004 were observed in the
85 II, 6. 3. 3 | per 100 000 per year in 1995, to below 40 per 100 000
86 II, 6. 3. 3 | has been decreasing since 1995, while in the UK, Belgium
87 II, 6. 3. 3 | Gonorrhoea within the EU, 1995 - 2004~ ~Syphilis~ ~Syphilis
88 II, 6. 3. 3 | per 100 000 per year in 1995), a sharp decrease in incidence
89 II, 6. 3. 3 | relatively stable period during 1995–2000, the incidence in Europe
90 II, 6. 3. 4 | A1.2 Cases of TB between 1995 and 2004~ ~ ~ ~Table 6.A1.
91 II, 6. 3. 4 | Trends of legionellosis 1995 - 2004.~ ~The incidence
92 II, 6. 3. 5 | decrease was observed between 1995 and 2000, but after 2002,
93 II, 6. 3. 5 | preventable by vaccination. Since 1995, the Baltic countries, in
94 II, 6. 3. 5 | incidence in Latvia peaked in 1995 (15 per 100 000 per year)
95 II, 6. 3. 5 | Lithuania the incidences in 1995 were about one tenth of
96 II, 6. 3. 5 | for Italy and Portugal in 1995. In the new Member States,
97 II, 6. 3. 5 | trend in Europe between 1995 - 2004.~ ~This drop is mainly
98 II, 6. 3. 5 | Estonia in 1998, France in 1995–96, Italy in 1995–96 and
99 II, 6. 3. 5 | France in 1995–96, Italy in 1995–96 and 1999–2000, Latvia
100 II, 6. 3. 5 | and 2002, in Lithuania in 1995 and 1999–2000, Czech Republic
101 II, 6. 3. 6 | trend from 85 000 cases in 1995, to 180 000–190 000 more
102 II, 6. 3. 6 | Campylobacteriosis trends between 1995 - 2004~ ~In 2005, more than
103 II, 6. 3. 6 | contaminated food. After a peak in 1995, the incidence of salmonellosis
104 II, 6. 3. 6 | steadily declining since 1995. The highest proportion (
105 II, 6. 3. 6 | reported by Italy between 1995 and 2004 (6 440 cases).
106 II, 6. 3. 6 | than doubled, rising from 1995 to 2002 and levelling off
107 II, 6. 3. 6 | Europe decreased between 1995 and 1998, but since then
108 II, 6. 3. 6 | was similar to that for 1995. Twenty-six countries reported
109 II, 6. 3. 6 | reported in Europe between 1995 and 2004, and during this
110 II, 6. 3. 6 | highest incidence observed in 1995 (1.68 per 100 000 per year),
111 II, 6. 3. 6 | blood transfusion.~ ~Since 1995, vCJD has been detected
112 II, 6. 3. 7 | the EU during the period 1995–2004, ranging from 0.1 to
113 II, 6. 3. 7 | travellers’ health.~Since 1995, France has accounted for
114 II, 7. 3. 2 | Standardised Death Rates (1995-2004, Index = 1995), EU27~ ~
115 II, 7. 3. 2 | Rates (1995-2004, Index = 1995), EU27~ ~
116 II, 8. 2. 2 | blindness was published in 1995 (Thylefors et al, 1995).
117 II, 8. 2. 2 | in 1995 (Thylefors et al, 1995). Since the publication
118 II, 8. 2. 2 | Global Data on Blindness in 1995, several population-based
119 II, 8. 2. 2 | World Health Organization. 1995;73(1):115-21.~WHO (2000):
120 II, 9 | Brown, 2007a; Prysak et al, 1995). Parity is known to be
121 II, 9. 1. 1 | HK, Alexander S, Berg CJ (1995) Maternal mortality in developed
122 II, 9. 1. 1 | Obstetrics & Gynecology 1995;86(4 Pt 2):700-5.~ ~Bai
123 II, 9. 1. 1 | MH, Varnoux N, Breart G (1995): Maternal deaths and substandard
124 II, 9. 1. 1 | Obstet Gynecol Reprod Biol 1995;58(1):3-7.~ ~Breart G, Barros
125 II, 9. 1. 1 | singleton gestations: USA, 1995-2000. J Matern Fetal Neonatal
126 II, 9. 1. 1 | Prysak M, Lorenz RP, Kisly A (1995): Pregnancy outcome in nulliparous
127 II, 9. 1. 1 | and older. Obstet Gynecol 1995;85(1):65-70.~Raymond EG,
128 II, 9. 1. 2 | Brown, 2007a; Prysak et al, 1995). Parity is known to be
129 II, 9. 2. 7 | mortality in Europe, 1955—1995. Eur J Cancer. 37:785-809.~ ~
130 II, 9. 3. 1 | in female cases between 1995-97 (WHO, 2001). The health
131 II, 9. 3. 1 | 65 or over from 4.2% in 1995 to 9.5% in 2025. The most
132 II, 9. 3. 1 | erectile dysfunction between 1995 and 2025 and some possible
133 II, 9. 3. 2 | 2001; Bouvier-Colle et al, 1995; Schuitmaker, 1998).~ ~The
134 II, 9. 3. 2 | informant network (Atrash et al, 1995). Nonetheless, problems
135 II, 9. 3. 2 | HK, Alexander S, Berg CJ (1995) Maternal mortality in developed
136 II, 9. 3. 2 | Obstetrics & Gynecology 1995;86(4 Pt 2):700-5.~Bai J,
137 II, 9. 3. 2 | MH, Varnoux N, Breart G (1995): Maternal deaths and substandard
138 II, 9. 3. 2 | Obstet Gynecol Reprod Biol 1995;58(1):3-7.~ ~Breart G, Barros
139 II, 9. 3. 2 | singleton gestations: USA, 1995-2000. J Matern Fetal Neonatal
140 II, 9. 3. 2 | Prysak M, Lorenz RP, Kisly A (1995): Pregnancy outcome in nulliparous
141 II, 9. 3. 2 | and older. Obstet Gynecol 1995;85(1):65-70.~ ~Raymond EG,
142 II, 9. 3. 3 | 20 quantitative studies (1995- May 2005) on individual
143 II, 9. 3. 3 | in France (Bajos et al, 1995). In Portugal 4.2% of men
144 II, 9. 3. 3 | Wellings K, Spira A, Field J. (1995): Sexual behaviour in HIV
145 II, 9. 4. 3 | per cent in the UK since 1995. In the 65-plus age group
146 II, 9. 4. 3 | 150 to 416 cases, between 1995 and 2003, whilst cases of
147 II, 9. 5. 3 | Lindstrand, 2006: Lindholm, 1995). Access to school sports
148 II, 9. 5. 6 | Publications~ ~Lindholm G (1995): ÎSkolgrden, -vuxnas bilder -
149 III, 10. 1. 1 | chronic diseases (Burke et al, 1995; Green and Potvin, 2004).
150 III, 10. 1. 3 | Milligan R, Thompson C (1995): Assessment of nutrition
151 III, 10. 2. 1 | school children between 1995 and 2003, with a more marked
152 III, 10. 2. 1 | marked increase between 1995 and 1999 (Figure 10.2.3.
153 III, 10. 2. 1 | around 73 000 (Farrell, 1995; EMCDDA, 2000). For countries
154 III, 10. 2. 1 | at: htt ~ ~Farrell, M. (1995) Drug prevention: a review
155 III, 10. 2. 1 | Health Education Authority, 1995). They are more likely to
156 III, 10. 2. 1 | Health Education Authority (1995): Health update 5: physical activity.
157 III, 10. 2. 1 | and fishery products from 1995 to 2002, whereas the average
158 III, 10. 2. 1 | fishery products, EU15, 1995-2002 (1995=100)~ ~Figure
159 III, 10. 2. 1 | products, EU15, 1995-2002 (1995=100)~ ~Figure 10.2.1.7.6.
160 III, 10. 3. 1 | and mortality in Europe 1995. Eur. J. Cancer 38, 99-166.~
161 III, 10. 3. 2 | and GDP by 25% between 1995 and 2005 (Figure 10.3.2.
162 III, 10. 3. 2 | GDP for EU Member States 1995–2005~ ~Figure 10.3.2.3.
163 III, 10. 3. 3 | Summary of general trends (1995–2005), main age groups affected (
164 III, 10. 3. 4 | Union during the period from 1995 to 2006. The most important
165 III, 10. 4. 2 | 2003;~Salleras et al., 1995~ ~ ~Process contaminants~ ~
166 III, 10. 4. 2 | lead-free petrol)~ ~ ~IPCS, 1995; De Hollander~et al., 1999~ ~
167 III, 10. 4. 2 | regulations~ ~Episode in 1995 in Ireland~Monitoring~Van
168 III, 10. 4. 2 | 95/69/EC of 22 December 1995 laying down the conditions
169 III, 10. 4. 2 | European Commission (1995): Decision No. 95/69/EC
170 III, 10. 4. 2 | 95/69/EC of 22 December 1995 laying down the conditions
171 III, 10. 4. 2 | Communities No. L 332, 30 December 1995.~ ~European Commission (
172 III, 10. 4. 3 | with a 20% increase from 1995 to 2003.~ ~Figure 10.4.3.
173 III, 10. 4. 5 | treated in Europe – Data 1995-2003” contains statistics
174 III, 10. 5. 3 | employment from 66 per cent in 1995 to 71 per cent in 2005 in
175 III, 10. 6. 1 | been performed in 1990, 1995, 2000 and 2005, has collected
176 IV, 11. 1. 5 | implications (Carter et al, 1995; Cheah, 1998). Also, if
177 IV, 11. 1. 5 | events (81.8%) (Wilson et al, 1995). Less research has been
178 IV, 11. 2. 2 | total health spending in 1995 to 2% in 2005), and the
179 IV, 11. 3. 2 | 2.5 in Austria (between 1995 and 2005), 3.8 in Belgium,
180 IV, 11. 6. 2 | responsiveness (Jones and Duncan 1995) and may be less susceptible
181 IV, 11. 6. 3 | impact (Evans and Barer, 1995; Creese, 1997). Furthermore,
182 IV, 11. 6. 5 | AO, Battista RN et al. (1995): "Proceedings of the 1994
183 IV, 11. 6. 5 | 46.~ ~Evans RG, Barer ML (1995): "User fees for health
184 IV, 11. 6. 5 | 4.~ ~Jones A, Duncan A (1995): Hypothecated taxation:
185 IV, 11. 6. 5 | RM, Runciman WB et al., (1995): "The quality in Australian
186 IV, 12. 4 | London, UK) - Established in 1995~http eu~To foster scientific
187 IV, 12. 5 | consider a gain of 5% between 1995 and 2001 to signify compression
188 IV, 12. 8 | France (1957)~Austria (1995)~Bulgaria (2007)~Italy (
189 IV, 12. 8 | Luxemb0urg (1957)~Finland (1995)~Ireland (1973)~Hungary (
190 IV, 12. 8 | 1981)~Malta (2004)~Sweden (1995)~Spain (1986)~Netherlands (
191 IV, 12. 10 | regulations~S.I. 135 of 1995 - import and export of certain
192 IV, 12. 10 | Presidential Degree 105/1995 “Minimum standards for safety
193 IV, 13.Acr | total health spending in 1995 to 2% in 2004), and the
194 IV, 13. 7. 5 | importance in this regard (EU, 1995).~ ~Article 8 of the Directive
195 IV, 13. 9 | European Commission (1995): Directive 95/46/EC of
196 IV, 13. 9 | Council of 24 October 168 1995 on the protection of individuals
|
|
| |
